CAR T therapy extends its reach to autoimmune diseases
暂无分享，去创建一个
[1] Gregory F. Wu,et al. Antigen-specific depletion of CD4+ T cells by CAR T cells reveals distinct roles of higher- and lower-affinity TCRs during autoimmunity , 2022, Science Immunology.
[2] H. Einsele,et al. CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models , 2022, Science Translational Medicine.
[3] A. Ekici,et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus , 2022, Nature Medicine.
[4] C. June,et al. Engineered cellular immunotherapies in cancer and beyond , 2022, Nature Medicine.
[5] Gregory M. Chen,et al. Decade-long leukaemia remissions with persistence of CD4+ CAR T cells , 2022, Nature.
[6] J. Epstein,et al. CAR-based therapies: opportunities for immuno-medicine beyond cancer , 2022, Nature Metabolism.
[7] A. Mackensen,et al. CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus. , 2021, The New England journal of medicine.
[8] M. Sadelain,et al. CAR T cells: Building on the CD19 paradigm , 2021, European journal of immunology.
[9] G. Illei,et al. Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus , 2011, Annals of the rheumatic diseases.
[10] R. Bonasio,et al. Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. , 2005, Immunity.